EGFR and non-small cell lung carcinoma: Studies have shown that lncRNAs LCETRL3 and LCETRL4 on chromosome 4q12 reduce the therapeutic sensitivity of EGFR-TKI in NSCLC by stabilizing TDP43 and EIF2S1 [11].